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Since little is known of how the primitive protozoan
parasite, Giardia lamblia, senses and responds to its
changing environment, we characterized a giardial pro-
tein kinase A (gPKA) catalytic subunit with unusual
subcellular localization. Sequence analysis of the 1080-
base pair open reading frame shows 48% amino acid
identity with the cyclic AMP-dependent kinase from
Euglena gracilis. Northern analysis indicated a 1.28-
kilobase pair transcript at relatively constant concen-
trations during growth and encystation. gPKA is
autophosphorylated, although amino acid residues cor-
responding to Thr-197 and Ser-338 of human protein
kinase A (PKA) that are important for autophosphoryl-
ation are absent. Kinetic analysis of the recombinant
PKA showed that ATP and magnesium are preferred
over GTP and manganese. Kinase activity of the native
PKA has also been detected in crude extracts using
kemptide as a substrate. A myristoylated PKA inhibitor,
amide 14-22, inhibited excystation with an IC50 of 3 mM,
suggesting an important role of gPKA during differenti-
ation from the dormant cyst form into the active tropho-
zoite. gPKA localizes independently of cell density to the
eight flagellar basal bodies between the two nuclei to-
gether with centrin, a basal body/centrosome-specific
protein. However, localization of gPKA to marginal
plates along the intracellular portions of the anterior
and caudal pairs of flagella was evident only at low cell
density and higher endogenous cAMP concentrations or
after refeeding with fresh medium. These data suggest
an important role of PKA in trophozoite motility dur-
ing vegetative growth and the cellular activation of
excystation.
Infection with Giardia lamblia is a major global cause of
water-borne diarrheal disease (1). Nonetheless, neither its ba-
sic biology nor the pathophysiology of infection is well under-
stood. To date, no giardial toxin or conventional virulence fac-
tor has been identified by biological (2) or genomic studies (3).
Therefore, it is critical to understand how the parasite survives
in the external environment and infects and colonizes a new
host. G. lamblia has two life cycle stages that are each remark-
ably well adapted to survival in very different and inhospitable
environments. The dormant, quadrinucleate cyst persists for
months in fresh cold water (4). Infection is initiated by inges-
tion of cysts (5). Exposure of cysts to gastric acid during pas-
sage through the host stomach triggers the rapid and dramatic
differentiation known as excystation. After entry into the small
intestine and stimulation by specific factors (6), the parasite
emerges and divides into two equivalent binucleate trophozo-
ites that attach to and colonize the human small intestine. The
cyst wall must remain intact during passage through the stom-
ach acid; however, once the cyst enters the small intestine, the
wall must open rapidly to enable the parasite to emerge and
attach to host enterocytes.
In the small intestine, giardial trophozoites are exposed to
complex and everchanging concentrations of hydrogen ions and
nutrients, as well as bile acids and digestive enzymes (7). As
enterocytes migrate to the tip of the villus, where they are
sloughed off into the lumen, attached trophozoites must be able
to sense and respond rapidly to environmental signals to re-
main in the small intestine. Since excystation entails such
rapid responses to environmental stimuli, we hypothesized
that protein kinase-mediated signaling might be very impor-
tant. Thus, cell-signaling pathways may be crucial to both
giardial colonization in the small intestine and to the cellular
activation of excystation. Although many protein kinase gene
fragments have been identified by large scale genomic sequenc-
ing (Ref. 8; see also the web site for the Giardia Genome Project
Database (Marine Biological Laboratory, Woods Hole, MA)),
there is little understanding of their potential roles in giardial
survival and growth in the small intestine or in regulation of
differentiation.
In many eukaryotic cells, cyclic AMP (cAMP)-dependent sig-
naling pathways play a critical role in regulating cell growth,
metabolism, and differentiation (10, 11). Protein kinase A
(PKA,1 EC 2.7.1.37), the defining enzyme of the cyclic AMP-de-
pendent signaling pathway alters protein activity by phospho-
rylation at serine/threonine residues within the motif RRX(S/T)
(12). PKA is one of the simplest protein kinases known because
of its dissociative mechanism of activation (13). PKA holoen-
zyme, a catalytically inactive form, is a tetrameric complex
containing two identical catalytic (C) subunits bound to a ho-
modimer of two regulatory (R) subunits (14). Cyclic AMP bind-
ing to the R subunit results in dissociation of the holoenzyme
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with release of active C subunit. The activated C subunit of
PKA can phosphorylate a number of intracellular proteins,
including enzymes, cytoskeletal proteins, ion channels, and
transcription factors (15). How the specific physiological effects
of cAMP can be mediated by a broad spectrum protein kinase
such as PKA is now being elucidated (16, 17). In a number of
diverse cell types, PKA is localized in proximity to substrates
by A kinase anchoring protein(s) that bind to both the R sub-
unit and to a specific cell structure, often cytoskeletal (18).
Targeting PKA to the proximity of phosphate acceptor protein
molecules associated with specific cell structures can also
achieve rapid responses to cAMP (16, 19).
Genes encoding three different C subunits and four different
R subunits of PKA have been identified in humans (20). In
higher eukaryotes, various combinations of R and C subunits
display differences in tissue distribution (21–23), which may
determine their functional specificity. The unique distribution
and subcellular localization of PKA isoforms in higher eu-
karyotes may represent a functional interaction with nearby
structures. In lower eukaryotes, three isoforms of PKA C sub-
unit have been identified from Drosophila melanogaster (24),
and from Saccharomyces cerevisiae (25). However, only one
gene encoding PKA C subunit has been reported from Caeno-
rhabditis elegans, Dictyostelium discoidium, Leishmania
major, and Trypanosoma cruzi (26–29). Dictyostelium PKA
plays a key role during differentiation and morphogenesis (30).
Similarly, PKA plays critical roles in differentiation of Leish-
mania and Trypanosoma (28, 29). In contrast, Saccharomyces
PKA appears to mediate cellular responses to various extra-
cellular stimuli, including nutrients and heat shock (31).
Here we report the cloning and functional characterization of
a giardial homologue of a PKA C subunit. Thus far, only a
single isoform of gPKA C subunit has been identified in large
scale sequencing efforts with ;3-fold coverage of the genome
(32). Our studies demonstrate that, although the biochemical
properties of the recombinant gPKA are largely similar to those
of the mammalian enzyme, gPKA has some noteworthy struc-
tural differences. We found that cellular distribution of PKA
was correlated with cell density and endogenous cAMP levels.
At all cell densities, PKA localized to the eight flagellar basal
bodies, which correspond to the centrosomes of higher eukary-
otic cell (33). However, at low cell inocula and higher endoge-
nous cAMP concentrations, PKA also localized to marginal
plates along the intracellular portions of the anterior and cau-
dal flagella. To our knowledge, this is the first indication of a
role for cell signaling in giardial flagellar-associated structures.
In addition, a PKA inhibitor greatly decreased giardial excys-
tation. Thus, PKA may play a key role in regulating trophic
behavior of the motile form, as well as cellular activation dur-
ing excystation.
EXPERIMENTAL PROCEDURES
Materials—Unless specified, all materials were obtained from
Sigma, Fisher, and Life Technologies, Inc.
Giardia Cell Culture and Differentiation—G. lamblia (WB clone C6,
ATCC no. 50803) were maintained in TYI-S-33 medium with 10%
bovine serum and bile (34). Encystation and excystation were induced
essentially as described by Meng et al. (35). Briefly, encystation was
induced by growing trophozoites for one culture cycle in TYI-S-33 me-
dium without bile (pre-encystation). Bile-deficient medium was poured
off along with unattached trophozoites and replaced with encystation
medium containing 0.25 mg/ml porcine bile and 10 mM lactic acid, pH
7.8, and incubated at 37 °C for the time specified. Total encysting
cultures were harvested at different time points by chilling and centrif-
ugation and subsequently used for RNA and protein extraction. Cysts
were harvested at 66 h by washing and incubating in cold double-
distilled water to lyse any trophozoites or incomplete cysts (35). Excys-
tation was induced by a two-step method that models cyst passage from
the cold hypotonic freshwater external environment into the warm,
acidic stomach, pH 4.0, 20 min, 37 °C (stage 1). Stage 2 models cyst
passage from the stomach into the small intestine with exposure to
slightly alkaline pH (8.0) and protease (1 mg/ml bovine trypsin type II)
for 1 h at 37 °C. Cysts were pelleted at 8300 3 g and resuspended in
growth medium for 60 min at 37 °C. Emerged motile trophozoites were
enumerated using a hemocytometer. The percentage of excystation was
calculated as the sum of the motile trophozoites and partially emerged
trophozoites divided by the initial number of viable cysts.
Inhibition of Excystation—Myristoylated PKA inhibitor (amide 14-
22, Calbiochem Novobiochem, San Diego, CA) was dissolved in water
and diluted into water (pre-excystation) or excystation solutions. Inhib-
itor peptide was initially screened with the inhibitor present during 1 h
before incubation at 4 °C and added again during stage 1 and 2 of
excystation, since cysts were pelleted between stages. However, inhib-
itor was not included in the emergence step in growth medium because
of possible effects on trophozoites. 50% inhibitory concentration (IC50)
was estimated by interpolation from concentration-inhibition curves.
Viability was determined by trypan blue exclusion (35). To determine
the stage(s) at which each inhibitor was effective, cysts were pre-
incubated with inhibitor (at a higher than IC50 concentration, 10 mM)
prior to stage 1 in water for 1 h at 4 °C, or during stage 1 or stage 2 of
excystation.
The mean inhibition was normalized to solvent controls for each
experiment. All experiments were repeated at least twice. Data shown
are mean (6 S.D.) for at least two independent experiments. The p
values were calculated by paired two-tailed Student’s t test with the
normalized comparison value set at 100% for control excystation (35).
PCR Amplification—A 250-base pair DNA fragment of PKA catalytic
subunit was obtained by PCR amplification of Giardia genomic DNA
using degenerate primers (upper primer, 59-TAC(T)A(C)GXGAC(T)C(T)
TXAAA(G)C(T)C-39; lower primer, 59-CCXAA(G)XG(C)A(C)(T)CCAC-
CAA(G)TC-39, where X is all four nucleotides). Primers were designed
on the basis of the consensus sequence in the catalytic subdomains VIB
and IX of the PKA catalytic subunit. Designed degeneracy allowed
every possible codon for the consensus amino acid residues to maximize
the probability of amplification. The amplified PKA fragment was pu-
rified, sequenced, and used to screen a Giardia cDNA library.
Screening of a cDNA Library—A G. lamblia WB clone C6 cDNA
library was made in lZAPII (Stratagene, La Jolla, CA) using a kit
(ZAP-cDNAR synthesis kit, Stratagene) according to the manufacturer’s
protocol. The library was screened for the full-length clone of PKA using
32P-labeled PKA probes as described previously (36). Five positive
plaques were obtained by screening ;6 3 105 plaque-forming units.
Positive plaques containing inserts were plaque-purified and inserts
cloned into pBluescript plasmids by in vivo excision using ExAssist
helper phage (Stratagene). Inserts were confirmed by restriction diges-
tion and cross-hybridization.
DNA Sequencing and Identity Analysis—A capillary electrophoresis-
based automated DNA sequencer (ABI Prism, 310 Genetic analyzer;
ABI, Foster City, CA) was used to sequence positive clones from the
cDNA library. A PCR-based reaction kit (ABI PrismTM dRhodamine
Terminator Cycle Sequencing Ready Reaction), ABI prism 310 capillar-
ies (61 cm 3 50 mm, inner diameter) and POP-6 for long-read sequenc-
ing were used according to the manufacturer’s protocol. Raw output was
analyzed using ABI Prism sequence analysis software. The entire se-
quence identity was compared with the NCBI data base using PSI-
BLAST. Multiple sequence alignment was done using MegAlign pro-
gram from DNASTAR (Madison, WI) software. Tertiary structure was
determined using SWISS-MODEL and Swiss-Pdb Viewer, an internet-
based tool for automated comparative protein modeling (37, 38).
Southern Blot and Northern Blot—Genomic DNA from Giardia was
isolated using standard protocol as described by Maniatis et al. (39).
Total RNA was extracted using an RNA isolation kit (Stratagene)
according to the manufacturer’s specification. 32P-Labeled gPKA cDNA
probes were used for hybridization as described previously (36). For
Northern blots, a strand-specific probe was synthesized and used as a
probe for gPKA. Briefly, 25–50 ng of the template DNA was labeled
using 100 pmol of antisense primer, [32P]dCTP, dNTP, and Klenow
(exo2) (Stratagene). Unincorporated nucleotides were removed using a
NucTrap push column (Stratagene).
Expression and Purification of Recombinant gPKA—The gPKA ORF
was cloned into a T7 polymerase-driven expression vector pET30Ek/
LIC (Novagen, Madison, WI) according to the manufacturer’s protocol.
Two primers (upper primer, 59-GACGACGACAAGATGGAAGATAT-
TCAAGTA-39; and lower primer, 59-GAGGAGAAGCCCGGTCTATTTA-
AATCCCAC-39) were designed to amplify the PKA ORF (1.08 kb) and
part of the vector sequence. The PCR product was treated with T4 DNA
polymerase and dATP only to use the exonuclease activity of the po-















lymerase to generate vector compatible overhangs. Pre-digested vector
and insert were annealed and used to transform BL21 (DE3) Esche-
richia coli cells. Induction of gPKA overexpression in BL21 (DE3) was
performed at 25 °C with 0.5 mM isopropyl-1-thio-b-D-galactopyranoside.
Expressed gPKA as a 47-kDa His tag and S tag fusion protein was
purified through His-Bind columns (Novagen) and used as antigen for
generation of polyclonal antibodies through a commercial vendor (Co-
Calico, Reamftown, PA). The His tag and S tag sequences added 6 kDa
of molecular mass to the fusion protein.
Western Blot and Immunodepletion Experiment—Trophozoites and
encysting cells were harvested, and total proteins (50 mg) were used for
the immunodetection of gPKA using the polyclonal antibody made
against recombinant protein. A chemiluminescence detection kit
(Pierce) was used to detect positive signals recognized by anti-gPKA
antibody using anti-rabbit HRP-conjugated secondary antibody.
Immunodepletion was done in a two-step process. Crude trophozoite
extracts (500 mg) in 100 mM Tris, pH 7.5 and 5 mM MgCl2 were diluted
in TAN buffer (10 mM Tris acetate, pH 8.0, 1% Nonidet P-40, 100 mM
NaCl) containing 1 mM sodium orthovanadate, 1 mM phenylmethylsul-
fonyl fluoride, 2 mM n-ethylmalemide, 1 mg/ml leupeptin, and 2 mg/ml
aprotinin. Ten mg of rabbit IgG was added to the extract and incubated
for 2 h at 4 °C to remove nonspecific binding of proteins to gPKA IgG.
Next, 150 ml of Protein A-agarose beads (50% slurry) was added and
incubated overnight at 4 ° C to remove rabbit IgG. Protein A beads were
separated next by centrifuging at 1,500 3 g for 5 min at 4 °C. The
supernatant was incubated with 50 mg of gPKA antibody for 6 h at 4 °C
followed by 200 ml of Protein A beads for 18 h at 4 °C. Protein A beads
were separated by centrifugation, and the supernatant was used for the
kinase assay.
Assay of PKA Activity—Trophozoites were grown to confluence, har-
vested at 700 3 g, and washed three times with PBS. They were lysed
in a medium containing 100 mM Tris, pH 7.5, and 5 mM MgCl2 and a
mixture of protease inhibitors (Sigma) using a French press (750 p.s.i.).
The lysate was centrifuged at 30,000 3 g, and the supernatant was
passed through a syringe filter (0.45 mm). The filtrate was used for the
kinase assay using kemptide (Calbiochem-Novobiochem Corp) as a
substrate. Fifty mg of crude extract or purified recombinant gPKA (5 mg)
was used in a reaction mix containing 100 mM Tris, 5 mM MgCl2, 0.2 mM
ATP, 0.2 mM kemptide, and 0.5 nM [g-32P]ATP. The reaction mix was
incubated at 30 °C for 10 min and spotted (40 ml) on phosphocellulose
filter discs. Filters were washed four times for 5 min each with 1%
phosphoric acid and bound radioactivity counted in a liquid scintillation
counter (LKB). Kinase assays using recombinant gPKA were conducted
in the presence or absence of the myristoylated PKA inhibitor 14-22
amide and a PKA-specific hexamer inhibitor (RGYALG) (Bachem) at
different concentrations. Assays using crude extract were performed in
the presence or absence of 4 mM cAMP (Calbiochem). The catalytic
parameters were measured under standard assay condition, and the
data were graphically fit to the Lineweaver-Burk form of the Michaelis-
Menten equation (40).
Immunofluorescence Analysis—G. lamblia trophozoites were inocu-
lated in growth medium at 350–2000 cells/ml in 12-well tissue culture
plates and allowed to grow and attach to 18-mm glass coverslips for
65–70 h in an AnaeroPack jar (Mitsubishi Gas Chemical Company, Inc.,
Japan) at 37 °C. Coverslips containing attached trophozoites were di-
rectly fixed in 100% chilled MeOH (220 °C) for 10 min at 220 °C and
further permeabilized with PBS containing 0.5% Triton X-100 for 10
min. Permeablized trophozoites were blocked for 1 h in blocking buffer
(5% goat serum, 1% glycerol, 0.1% BSA, 0.1% fish gelatin, and 0.04%
sodium azide in PBS), and incubated with rabbit anti-gPKA polyclonal
antibodies (1/2500 in blocking buffer) and/or mouse monoclonal anti-
centrin antibodies (clone 20H5, 1/500 in blocking buffer) (41) for 1 h. At
the end of incubation, cells were washed for 5 min (four times) with PBS
and incubated with the secondary antibodies (anti-rabbit ALEXA 488
and/or anti-mouse ALEXA 568 (Molecular Probes, Eugene, OR) each
diluted in blocking buffer 1/800) for 1 h. Next, cells were washed for 5
min (four times) with PBS, post-fixed for 7 min with 4% paraformalde-
hyde (Electron Microscopy Sciences, Ft. Washington, PA) in PBS,
rinsed with PBS, and mounted on glass slides in Prolong (Molecular
Probes). Localization of gPKA and centrin was observed on a Zeiss LSM
510 laser scanning confocal microscope equipped with argon-krypton
(455/488) and helium-neon (543/633) lasers and appropriate filter sets.
cAMP Measurements—To measure endogenous cAMP levels in var-
ious stages of G. lamblia growth, a competitive cAMP enzyme immu-
noassay (Biotrack Cellular Communications Assays, Amersham Phar-
macia Biotech) was employed. G. lamblia were cultured as described for
immunolocalization. Using the nonacetylated protocol 3 method of the
Biotrack enzyme immunoassay, parasites were lysed in a 500-ml vol-
ume of lysis reagent and the amount of cAMP was determined by the
manufacturer’s protocol. The enzyme immunoassay was repeated five
times with parasites from independent cultures, and cAMP measure-
ments were done in duplicate for each sample. Mean differences in the
amount of cAMP levels between different cell densities were compared
using a paired Student’s t test, and p values # 0.05 were considered
significantly different.
RESULTS
Sequence and Expression Analyses of gPKA—Upon screening
a Giardia cDNA library with a 250-base pair probe derived
from conserved PKA sequences, a 1.28-kb fragment containing
an ORF of 1.08 kb (360 amino acids) corresponding to a Giardia
homologue of PKA catalytic subunit was cloned (Fig. 1). An
unusually long 189-base pair 39-untranslated region was pres-
ent in the cloned fragment (accession no. AF181097).
The translated amino acid sequence of the ORF showed 48%
identity with E. gracilis, 45% identity with C. elegans, 43%
identity with human, and 41% identity with yeast cyclic AMP-
dependent PKA catalytic subunit with probability scores be-
tween 3e-77 and 2e-69 as obtained from PSI-BLAST homology
search of the NCBI data base. Since the serine-threonine ki-
nase family exhibits a significant degree of conservation of the
kinase domains, the gPKA ORF also showed limited homology
with a number of other serine threonine kinases, such as cGMP-
dependent protein kinases. However, probability scores (start-
ing at 2e-57 for human KGPA) were significantly lower, and
gPKA does not have a cyclic GMP-binding domain.
The identification of the ORF as a PKA homologue was
strengthened by the presence of most of the key functional
motifs, as predicted by comparison with the crystal structure of
bovine PKA C subunits (PKAc) (42). The amino acid sequence
analysis of gPKA shows the presence of all 11 subdomains of
the kinase domain of PKAc (Fig. 1). Because of its early evolu-
tionary position (43), giardial genes are frequently highly di-
vergent (8). Despite the lower degree of identity, gPKA exhibits
the important consensus motifs, which include the glycine-rich
consensus motif GXGXXGXV (Gly-24 to Val-31 using the
amino acid numbers of the giardial sequence) in subdomain I,
the APE (Ala-190 to Glu-192) motif in subdomain VIII and the
catalytic loop YRDLKXXN (Tyr-138 to Asn-145) in subdomain
IV. The glycine loop is involved in interactions with ATP
b-phosphate oxygens and the pseudosubstrate peptides such as
the PKA inhibitor peptide (PKI). The APE motif helps to sta-
bilize the large C-terminal lobe of PKAc. Highly conserved
amino acid residues such as Lys-46 in subdomain II, which is
responsible for ATP-binding; Glu-65 in subdomain III, which
interacts with Lys-46; and Arg-264 in subdomain IX are also
present. Among the consensus residues for interaction with the
R subunit of PKA or PKI, only His-61 in subdomain III, Arg-
107 (not conserved in PKAcg), and Arg-108 in subdomain V are
present but Trp-196, Thr-197, Leu-198, and Lys-213 (in verte-
brates) in subdomain VIII are not. The consensus residue Thr-
197 (in vertebrates) that is responsible for autophosphorylation
in other species is replaced by a serine residue, which can also
be phosphorylated in gPKA (Ser-181). In subdomain VII, the
Phe residue in DFG sequence is also substituted by another
hydrophobic residue Leu in gPKA. This triplet helps to orient g
phosphate for transfer to the substrate by chelating the Mg21
ion, which bridges the b and g phosphates of the ATP. The
invariant Arg-280 (Arg-264 in gPKA) responsible for stabilizing
the large lobe of PKAc is also present.
Analyses of Southern blots and large scale genomic sequence
(32) suggests that gPKA is a single-copy gene. Northern and
Western analyses showed that gPKA was expressed apparently
at a constant concentration during both growth and encysta-
tion as a 1.3-kb transcript and a 41-kDa protein (data not
shown).















gPKA Has a Predicted Additional Loop in the Activation
Domain—Using an internet-based protein modeling program
(37, 38), we compared the three-dimensional structure of gPKA
to the a-catalytic subunit of bovine PKA complexed with the
inhibitor staurosporine (PDB accession no. 1STC) and H8 pro-
tein kinase inhibitor (PDB accession no. 1YDS) (Fig. 2A). How-
ever, this is a predicted three-dimensional structure based on
the actual crystal structure of the template complexed with
inhibitors, which may contribute some degree of inaccuracy.
Nonetheless, the superimposed structure of gPKA indicates
two major differences. A small loop (red) is in subdomain XI at
the C-terminal end of the kinase domain (Fig. 2, A and B). The
interaction of the invariant arginine corresponding to Arg-280
(Fig. 2B, yellow arrow), which stabilizes the large lobe by form-
ing an ion pair with Glu-208 is predicted to be present in gPKA
(Arg-254 and Glu-182) but the hydrogen (H) bond between
Arg-280 and Asn-283 appears to be missing in gPKA. Asn-283,
which maintains the loop structure by forming a H-bond with
Leu-277 in the template, is replaced by Ser-258 forming a
H-bond with Lys-251 in gPKA, thus making the loop more
relaxed than that in the template.
The other major difference is the large loop in the activation
domain (subdomain VIII shown in red in Fig. 2 (A, C, and D)).
A unique stretch of 10 amino acids from Asn-169 to Leu-178, is
predicted to form an additional loop creating a distinct change
in the conformation of the activation domain (Fig. 2, C and D).
Specifically, Ser-171 (Thr-197 in the template) does not form
H-bonds with Lys-153 (Lys-189) and Thr-169 (Thr-195), which
are present in the crystal structure of the 1YDS template.
These ion pairs may stabilize the subdomain VIII in an active
conformation, thereby permitting proper orientation of the sub-
strate peptide. The presence of several H-bonds in the extra
loop indicates a highly stable configuration, which may inter-
fere with the binding of the PKI inhibitor. The Mg21 binding
domain DFG (Asp-184 to Gly-186), although replaced by DLG
(Asp-148 to Gly-150) in gPKA shows a similar conformation
with H-bond formation between Leu-149 and Ala-152 (Fig. 2C).
Another minor difference is in the subdomain IX representing
the large a-helix in the large lobe (Fig. 2E). The invariant
Asp-220 (Asp-194 in gPKA), which acts to stabilize the YRD-
KXXN catalytic loop by forming H-bonds with backbone amides
of Arg-165 and Tyr-164 is predicted to form H-bond only with
Arg-129 but not with Tyr-128 in gPKA. This may cause insta-
bility in loop formation.
Recombinant gPKA Is Catalytically Active—We determined
the catalytic activity of the purified recombinant gPKA using
histone (Fig. 3) and kemptide (see below) as substrates. Kemp-
tide is a synthetic heptapeptide (LRRASLG) and is highly
specific for PKA. Recombinant gPKA phosphorylated both sub-
strates (specific activity 6.2 6 0.2 nmol of phosphate/min/mmol
of enzyme) and was also capable of autophosphorylation (Fig. 3,
A and B). Purified gPKA autophosphorylated in a concentra-
tion dependent manner with a stoichiometry of 1–1.8 mol of
phosphate/mol of gPKA. Phosphorylated PKA increased with
incubation time and was not observed in the control lane with-
out enzyme. The recombinant PKA band is also absent from the
control no extract lane in the protein gel (Fig. 3A). Apparent Km
values for Mg21ATP and kemptide are in the micromolar
range: kemptide (7.5 6 8.5 mM), Mg21 (127 6 10 mM), and ATP
(11.18 6 4.5 mM as phosphate donor). The apparent Km for ATP
and the synthetic peptide kemptide are in the range close to
that of cytosolic type II PKA from erythrocyte and from bovine
heart (44, 45). The Km for Mg
1 for gPKA is in the micromolar
range instead of the millimolar range that has been reported
for vertebrate PKAc (42). Additionally, Mg21 is preferred over
Mn21 as the divalent cation and ATP over GTP as the phos-
phate donor for optimum activity (data not shown). Kinase
activity of recombinant gPKA with histone or kemptide was not
inhibited by the 6-22 amide (PKI), which is potent inhibitor of
mammalian PKAs (data not shown). However, both the shorter
myristoylated peptide inhibitor, 14-22 amide (which inhibited
giardial excystation, see below) and a PKA-specific synthetic
FIG. 1. Multiple sequence alignment of gPKA. Gl, G. lamblia; Ce, C. elegans; Eg, E. gracilis; Hs, H. sapiens; Sc, S. cerevisiae. The solid bars
above the sequences indicate the G loop, catalytic loop, and APE sites, respectively. The black arrow indicates the conserved Lys-64 for ATP
binding. The asterisk indicates conserved Glu-65, which interacts with Lys-46. The triangle shows Ser-181 instead of Thr-197 required for
autophosphorylation in other species. The diamond shows Leu instead of Phe in sequence DFG, and the filled circle shows Arg-264.






























hexapeptide inhibitor (RGYALG) were able to inhibit phospho-
rylation of kemptide by gPKA with IC50 values of 10 mM (Fig.
3D) and 3 mM, respectively. The IC50 of the hexapeptide inhib-
itor was lower than that obtained with the PKA from rabbit
skeletal muscle (46).
Catalytically Active PKA Is Present in Giardia Trophozo-
ites—We measured the phosphorylating ability of the native
PKA in the crude extracts of trophozoites using kemptide as
the specific substrate (Fig. 4). PKA activity was monitored in
the presence or absence of kemptide (Fig. 4B) to eliminate
phosphorylation of endogenous substrates by PKA and other
kinases. A 5-fold increase in activity was obtained with kemp-
tide, indicating active gPKA in the trophozoite extracts (specif-
ic activity 1.2 6 0.26 nmol/min/mg of protein). Exogenous
cAMP at a concentration (4 mM) slightly higher than that used
for the mammalian PKA was able to stimulate gPKA activity in
the crude extract. A 2.5-fold increase in kemptide phosphoryl-
ation was noted following addition of cAMP in the crude extract
(p , 0.02) (Fig. 4C). To confirm that the activity was due to
native PKA, we immunodepleted gPKA from crude trophozoite
extracts by immunoprecipitation using a rabbit polyclonal an-
tibody against recombinant gPKA. The specificity of the gPKA
antibody was shown by its reaction with the 47-kDa recombi-
nant gPKA and with a single 41-kDa polypeptide in the crude
extract in Western blot at a dilution of 1:7000 (Fig. 4A). The
idea that the cAMP-stimulated posphorylation of kemptide in
crude extracts was due to gPKA was also supported by immu-
nodepletion studies. As expected, addition of kemptide did not
increase kinase activity of the depleted crude extract (Fig. 4B).
Depletion of the native PKA was confirmed by Western blot
analysis, which shows no PKA protein band in the depleted
lane (Fig. 4A). The higher band in this lane is the residual PKA
IgG that reacted with anti-rabbit secondary antibody.
Immunolocalization of gPKA and cAMP Measurements in
Trophozoites—The cellular localization of PKA enzyme in G.
lamblia trophozoites was determined using primary antiserum
generated to purified recombinant Giardia PKA (or anti-gPKA)
and confocal microscopy. At low cell densities (achieved with
inocula of 350–700 cells/ml), distinct signals were seen in dense
rods or marginal plates along the intracellular portions (axon-
emes) associated with the pairs of anterior and caudal flagella,
as well as in the eight basal bodies located between the nuclei
(Fig. 5A). Localization of gPKA to the flagellar basal bodies was
confirmed by colocalization with monoclonal anti-centrin anti-
body (41) (Fig. 5B). In addition to the basal bodies, anti-centrin
localized along the two axonemes associated with the posterior-
lateral flagella that were not recognized by gPKA (Fig. 5B).
Neither antibody reacted in the region of the ventro-lateral pair
of flagella. Localization of gPKA at high cell density (inocu-
lum . 1400 cells/ml) also showed staining of basal bodies.
However, there was no localization to axonemes and diffuse
staining was observed in the cytosol (Fig. 5C). Refeeding cells
from the higher inocula cultures with fresh medium for 10 min,
led to the localized patterns (Fig. 5A); however, exposure to
exogenous dibutyryl cAMP did not (data not shown). Results
from the cAMP analyses showed that those cells having a
diffuse staining pattern (Fig. 5C) had significantly (p , 0.03 for
comparisons of 700 with 1400 and 2000 cells/ml) lower endog-
enous levels of cAMP compared with those parasites with lo-
calized staining (Fig. 5A) to flagellar marginal plates compo-
Fig. 2. Analysis of predicted three-dimensional structure of gPKA. A, comparison of the predicted three-dimensional structure of gPKA
(blue) and crystal structure of the a-catalytic subunit of bovine PKA complexed with staurosporine (white). Structures of gPKA and the template
are represented as blue and white ribbons, respectively. Any change in the color of the blue ribbon represents dissimilarities with the template.
Increasing color intensity represents increasing degree of mismatches leading to red representing absolute differences between gPKA and the
template. Arrows indicate the additional loop structure in gPKA. B, comparison of the structure of the loop in subdomain IX. Blue, gPKA; white,
a-catalytic subunit of bovine PKA complexed with H8 inhibitor peptide (PDB accession no. 1YDS). Yellow arrows indicate the invariant Arg-280
(Arg-254 in gPKA). Red arrow indicates the H-bond that is missing from gPKA. C, comparison of the activation domains of gPKA (blue) and bovine
PKAc-a (white). The orange arrow indicates the H-bond in the Mg21-binding domain when Phe-185 is replaced by Leu-149 in gPKA. D, structures
of the activation domains of gPKA (blue) and bovine PKAc-a complexed with H8 inhibitor peptide (white). Orange arrows indicate H-bonds that
are missing between Lys-153 and Thr-165 and between Lys-153 and Ser-171 (Lys-189 and Thr-195, and Lys-189 and Thr-197 in bovine PKAc)
making the loop more relaxed. Purple arrows show the bond that is missing between Thr-165 and Ser-171 (Thr-195 and Thr-197 in bovine PKAc).
Red loop indicates several H-bonds that are absent in bovine PKAc. E, comparison of the subdomain IX of gPKA (blue) and bovine PKAc-a (white).
Orange arrows indicate the invariant Asp-194 (Asp-220 in bovine PKAc). Purple arrows indicate the H-bond that is missing between Asp-194 and
Tyr-128 (Asp-220 and Tyr-164 in bovine PKAc) needed to stabilize the catalytic loop.
FIG. 3. Phosphorylation of histone
by gPKA at different incubation time
(0–30 min). A, Coomassie Blue-stained
gel showing equal amounts of histone and
gPKA in all lanes except in lane N. N
contains histone but no extracts. B, auto-
radiogram showing phosphorylated his-
tone and gPKA. C, Lineweaver-Burk plot
of the phosphorylation of kemptide by
gPKA at 30 °C. Each point represents the
mean of three separate experiments. Ap-
parent Km for kemptide, ATP, and Mg
21,
and specific activity of gPKA are pre-
sented in the box. D, inhibition of phos-
phorylation of kemptide by myristoylated
PKA inhibitor 14-22 and by the synthetic
hexapeptide inhibitor (RGYALG). Data
represented as mean 6 S.D. (* indicates
p , 0.03 (n 5 3) for the myristoylated
inhibitor and p , 0.005 (n 5 2) for the
hexapeptide; ** indicates p , 0.04).















nents (Fig. 5D). This suggests that localization of gPKA to the
flagella is responsive to both cell density and growth factors.
Involvement of gPKA in the Excystation Process—Since ex-
cystation is a very rapid differentiation in response to extreme
changes in the external milieu, intracellular signaling may be
more important than changes in gene expression. Cyclic AMP
is important in cellular differentiation in other organisms, and
we asked if PKA activity might be needed for excystation. We
found that a cell-permeable myristoylated pseudosubstrate in-
hibitor specific for PKA (amide 14-22) inhibited excystation
with an IC50 of 3 mM when it was present throughout excysta-
tion (Fig. 6A). The effect of the PKA inhibitor on the individual
stages of excystation was also studied. Pre-incubating cysts
with the PKA inhibitor prior to excystation stimuli was effec-
tive in preventing excystation. The inhibitor was also effective
at the low pH stage 1, which mimics passage through the
stomach, but less effective at stage 2, which mimics cyst entry
into the host small intestine (Fig. 6B). Since this stage entails
digestion of cysts with trypsin, it is likely that the peptide
inhibitor was at least partly inactivated. These studies suggest
a need for PKA activity during the early stages of excystation.
DISCUSSION
Since PKA regulates critical cellular processes in both higher
and lower eukaryotes, we characterized a homologue of a PKA
catalytic subunit of Giardia. Sequence and structural predic-
tions showed that most of the kinase subdomains that are
conserved in higher eukaryotes, are present in gPKA, and we
have also identified a regulatory subunit homologue (data not
shown), suggesting a conventional PKA holoenzyme. Despite
several structural differences, functional characterization dem-
onstrates that both recombinant and native PKA are catalyti-
cally active and phosphorylate a PKA-specific substrates, such
as kemptide as well as histone. Structural alignments, sub-
strate specificity, and stimulation of the kinase activity of
native PKA by cAMP all suggest that the cloned ORF is indeed
a Giardia homologue of the C subunit of PKA.
In the case of a ubiquitous enzyme, such as PKA, it is
important to understand how different physiological conditions
determine specificity. A prominent level of control is to localize
signaling proteins to specific subcellular organelles or compart-
ments. Thus, it is very interesting that, in Giardia, PKA can
localize to both basal body/centrosome and specific flagellar
structures. In certain cells, protein kinase A-anchoring pro-
teins or AKAPs can bind to a PKA regulatory subunit, which
then localizes the catalytic subunit to the proper structure. For
example, AKAP450 targets PKA to centrosomes in HeLa cells
(47). In bovine and human sperm, mAKAP82 localized PKA,
via its RII subunit, to the fibrous sheath (48), between the
axoneme and the surrounding mitochondrion. In contrast, PKA
of a single-celled flagellated alga, Chlamydomonas, is reported
to be localized to the radial spokes of the flagellar structure,
where it may be involved in regulating dynein ATPase (49).
The location of PKA in giardial flagellar structure appears
closer to that of mammalian sperm than to that of
Chlamydomonas.
Immunolocalization of gPKA in trophozoites showed a selec-
tive accumulation of PKA in the eight flagellar basal bodies at
low and high cell densities. Localization of PKA to the basal
bodies was confirmed by colocalization with centrin, a basal
body-specific Ca21-binding protein. Basal bodies are rodlike
structures associated with the origins of the flagellar axonemes
and are involved in cell motility. The basal bodies of flagellated
cells correspond to the centrosomes of higher eukaryotic cells
(50). Centrin, which is found in centrosomes in higher eu-
karyotes and basal bodies of all flagellated and ciliated cell
types including Giardia (51), is also involved in mitotic spindle
pole segregation in Saccharomyces (52). Interestingly, se-
quence analyses have shown that a giardial centrin gene has a
motif that predicts phosphorylation by PKA. Indirect immuno-
fluorescence studies revealed that antibody specific for phos-
phorylated centrin reacted with the basal bodies of dividing
cells, but not interphase cells.2 Thus, centrin in the basal
bodies may be a substrate for phosphorylation by PKA during
a specific stage of the cell cycle. In contrast, gPKA was associ-
ated with the paired anterior and caudal flagella only at low
cell densities, which correlated with higher endogenous cAMP
levels. This is the first evidence that trophozoites can respond
to signals from their environment with changes in cAMP levels
2 W. L. Lingle and J. L. Salisbury, personal communication.
FIG. 4. Detection of active gPKA in
trophozoite extracts. A, Western blot.
Detection of gPKA in trophozoite extracts
before and after immunodepletion of
gPKA by PKA antibody. The PKA IgG
band in the depleted extract lane is the
remaining gPKA antibody recognized by
the anti-rabbit secondary antibody. B,
kinase activity in crude extracts and im-
munodepleted extracts using kemptide
as the substrate. Data represented as
mean 6 S.D. (n 5 3). C, effect of exoge-
nous cAMP on the kinase activity in the
crude extract. Data represented as
mean 6 S.D. (p , 0.02, n 5 4).















and altered localization of a protein kinase. Since the flagellar
localization was also found after refeeding high density cul-
tures, it is likely a response to growth factors.
Giardia has four pairs of eukaryotic flagella (5) that are
responsible for both motility and attachment. Each originates
from a basal body between the two nuclei and every pair of
flagella traverses part of the cell body and emerges at a specific
location. Paraflagellar densities or marginal plates have been
observed by electron microscopy, along much of the intracellu-
lar portion of all four pairs of flagella, but little is known about
the composition or function of the marginal plates (53). Only
the extracellular portions of the flagella are covered with
plasmalemma.
The ability of trophozoites to alter their flagellar motility in
response to external conditions may be critical to their ability
to colonize the small intestine where the availability of growth
factors is constantly changing. The anterior flagella cross an-
teriorly from the basal bodies and pass through the cell’s ven-
trolateral flange before exiting the cell body. The ventrolateral
flange is the outer margin of the cell body that interdigitates
between microvilli of the small intestinal enterocytes (9), along
with the ventral adhesive disc in trophozoite attachment. The
ventrolateral flagella, stained for centrin, but not for PKA.
Both the anterior and ventrolateral flagella are important in
forward motion of the trophozoite and continue to beat while
the parasite is attached to intestinal enterocytes or to inert
substrates. In contrast, the caudal flagella, whose marginal
plates also stained for PKA, do not appear to beat during
swimming or attachment and have a rigid appearance, very
distinct from the helical form of the other flagella (9). The
FIG. 5. Immunolocalization of gPKA and analysis of cAMP levels in G. lamblia trophozoites. A, at low cell density, anti-gPKA
recognizes the intracellular portions of caudal flagella (CF), anterior flagella (AF), and the basal bodies (BB) located between the nuclei. B, centrin
localization to the posteriolateral flagella. Colocalization of centrin and gPKA was observed to the basal bodies shown in yellow and indicated by
an arrow. C, gPKA was associated with basal bodies (arrow) and the cytosol, but not the flagella, at high cell densities. D, trophozoites that had
localized (L) staining to caudal flagella and anterior flagella had significantly higher (*) levels of endogenous cAMP, compared with trophozoites
that appeared to have diffuse (d) staining in the cytosol. Data are represented as mean femtomoles of cAMP/105 cells 6 S.D. (n 5 5).















caudal flagella are thought to be associated with dorsal flexion
of the “tail” of the cell body that is involved in trophozoite
detachment. Since Giardia attach to enterocytes, which mi-
grate to the tip of the villus and are then sloughed off, tropho-
zoites must be able to detach, swim, and re-attach to younger
host cells to remain in the small intestine. Our finding of
association of gPKA with anterior and caudal flagella, whereas
centrin associates with the posterior-lateral flagella, may help
understand differential flagellar function. Localization of
gPKA and centrin to structures responsible for both motility
and cell division may link those functions in an ancient eu-
karyote. These data support a role for PKA and cAMP in
regulating giardial attachment and locomotion.
Blocking excystation with the cell permeable PKA inhibitor
(amide 14-22) suggests a key role for gPKA in this critical
differentiation. The role of PKA appears most critical early in
excystation. Cysts are ingested from cold freshwater and are
first exposed to the highly acidic gastric fluid (pH 2.0 to pH 4.0),
which is needed for the induction of excystation (35) and is
modeled by our stage 1 in vitro. PKA inactivation prior to or
during stage 1 appears to interfere with the induction pro-
cesses (Fig. 6B). Giardial excystation entails a dramatic re-
sumption of flagellar motility and cell division. In vivo, excyst-
ing cells must regain their motility and attach before they are
carried downstream by the flow of intestinal fluid. Therefore,
the localization of PKA in flagellar and basal body structures
may reflect a role in motility and cytokinesis in excystation as
well as in vegetative growth.
Structural analyses of gPKA suggested both a high degree of
conservation and possibly significant divergences. Key con-
served motifs include the glycine-rich motif, reactive loop, and
Thr-197 residue for autophosphorylation. The most unusual
feature of gPKA is a highly stable loop in the activation domain
(subdomain VIII) of the enzyme as indicated in the predicted
three-dimensional structure (Fig. 2C). This loop may interfere
with the interaction of gPKA with PKI (6-22 amide) but not
with the shorter 14-22 inhibitor or the heptapeptide substrate,
kemptide. We hypothesize that gPKA can interact with the
shorter inhibitory peptide, but not the longer, possibly because
the extra loop in the activation domain of gPKA that could
interfere with binding of the larger inhibitor. The catalytic
activity of native gPKA should be due to catalytic subunits that
have dissociated from the holoenzyme in response to increased
cAMP. Exogenous cyclic AMP at a slightly higher concentration
than for the mammalian enzyme-activated gPKA activity.
At present, the precise physiological stimuli that affect
cAMP levels and PKA activity and localization in Giardia are
not known. In Saccharomyces, the stimuli are very simple; only
glucose or cytosolic acidification is known to increase cAMP
concentrations. Yeast must respond to transiently favorable
growth conditions that allow stationary phase cells to switch to
a growth program. Perhaps Giardia’s needs are more complex,
as its environment changes drastically during excystation.
Moreover, within the small intestine, conditions change rapidly
according to whether trophozoites are attached to young or
senescent enterocytes, or are in the lumen and according to the
nutritional status of the host. Our data suggest key roles for
PKA in regulating giardial responses to its environment.
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